Business Description
Cizzle Biotechnology Holdings PLC
ISIN : GB00BNG2VN02
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.86 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 45 | |||||
3-Year EPS without NRI Growth Rate | 45 | |||||
3-Year FCF Growth Rate | 56.3 | |||||
3-Year Book Growth Rate | 10.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 58.88 | |||||
9-Day RSI | 59.41 | |||||
14-Day RSI | 59.06 | |||||
6-1 Month Momentum % | 18.92 | |||||
12-1 Month Momentum % | 2.33 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 7.16 | |||||
Quick Ratio | 7.16 | |||||
Cash Ratio | 6.33 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -208.4 | |||||
Shareholder Yield % | -7.54 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -164.28 | |||||
ROA % | -150.67 | |||||
ROIC % | -56.48 | |||||
3-Year ROIIC % | -1414.76 | |||||
ROC (Joel Greenblatt) % | -924.73 | |||||
ROCE % | -52.39 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 9.75 | |||||
EV-to-EBIT | -8.71 | |||||
EV-to-Forward-EBIT | -3.38 | |||||
EV-to-EBITDA | -8.71 | |||||
EV-to-FCF | -12.57 | |||||
Earnings Yield (Greenblatt) % | -11.49 | |||||
FCF Yield % | -6.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Cizzle Biotechnology Holdings PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.008 | ||
Beta | 0.64 | ||
Volatility % | 54.91 | ||
14-Day RSI | 59.06 | ||
14-Day ATR (€) | 0.000832 | ||
20-Day SMA (€) | 0.022125 | ||
12-1 Month Momentum % | 2.33 | ||
52-Week Range (€) | 0.0155 - 0.03 | ||
Shares Outstanding (Mil) | 396.39 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cizzle Biotechnology Holdings PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cizzle Biotechnology Holdings PLC Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Cizzle Biotechnology Holdings PLC Frequently Asked Questions
What is Cizzle Biotechnology Holdings PLC(FRA:E7F0)'s stock price today?
When is next earnings date of Cizzle Biotechnology Holdings PLC(FRA:E7F0)?
Does Cizzle Biotechnology Holdings PLC(FRA:E7F0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |